تفاعل #10469

ord-77fb5b5bec6a4685847a43aba0b3d881

معادلة التفاعل

COC(=O)c1c(C)cccc1CO[C@H]1CCC[C@@H](O)C1
racemic methyl cis-2-(3-hydroxycyclohexyloxymethyl)-6-methylbenzoate
COC(=O)c1c(C)cccc1CO[C@H]1CCC[C@@H](O)C1
Racemic Methyl cis-2-(3-hydroxycyclohexyloxymethyl)-6-methylbenzoate
COC(=O)c1c(C)cccc1CO[C@@H]1CCC[C@H](O)C1
methyl (1R,3S)-2-(3-hydroxycyclohexyloxymethyl)-6-methylbenzoate

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    workup.ADDITIONa further 2 g of Novozym 435 were added
  2. 2
    أخرىAfter a total of 44 h
  3. 3
    ترشيحby filtering off the enzyme
  4. 4
    تركيزthe filtrate was concentrated by evaporation under reduced pressure
  5. 5
    أخرىto obtain 540 g

الإجراء التجريبي

490 g of the crude, racemic methyl cis-2-(3-hydroxycyclohexyloxymethyl)-6-methylbenzoate (see Example 1) were dissolved in 3.1 l of methylene chloride and 850 ml of vinyl acetate, admixed with 18 g of Novozym 435 and stirred at 21–24° C. After 28 h, a further 2 g of Novozym 435 were added. After a total of 44 h, the reaction was ended by filtering off the enzyme and the filtrate was concentrated by evaporation under reduced pressure to obtain 540 g. Chromatography of the residue on approx. 6 kg of silica gel (1:1 ethyl acetate/n-heptane) gave 184 g of methyl (1R,3S)-2-(3-hydroxycyclohexyloxymethyl)-6-methylbenzoate; >98% ee (HPLC on Chiralpak AD-H 250×4.6; 1 ml/min, heptane/EtOH/CH3CN 25:1:0.5+0.1% TFA); 1H NMR (CDCl3), δ =1.27 (m, 1H), 1.45 (m, 1H), 1.55 (m, 1H), 1.74 (m, 1H), 1.83 (m, 1H), 2.05 (m, 1H), 2.34 (s, 3H), 3.47 (m, 1H), 3.72 (m, 1H), 3.91 (s, 3H), 4.58 (dd, 2H), 7.15 (d, 1H), 7.20 (d, 2H), 7.27 (m, 1H) and 239 g of the (1S,3R)-acetate (93% ee, HPLC on Chiralcel OD/20 250×4.6, 1 ml/min, 100:1:0.5 heptane/EtOH/CH3CN).

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US07094795B2uspto-grants-2006_08